What is the treatment for a subconjunctival hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Subconjunctival Hemorrhage

No specific treatment is required for subconjunctival hemorrhage—observation alone is appropriate as this is a benign, self-limiting condition that resolves within 1-2 weeks without intervention. 1, 2

Primary Management Approach

  • Observation is the mainstay of treatment for isolated subconjunctival hemorrhage, with artificial tears used only for symptomatic relief of mild irritation 1, 2
  • Patient education about the natural resolution timeline (1-2 weeks) is essential to prevent unnecessary anxiety and follow-up 1, 2

Symptomatic Relief Options

  • Artificial tears can be applied as needed to relieve mild irritation or foreign body sensation 1, 2
  • Cold application may provide comfort when applied for 20-30 minutes per session using ice and water in a bag surrounded by a damp cloth, with a barrier (such as a thin towel) between the cold source and skin to prevent cold injury 2

When to Investigate Further: Red Flags for Recurrent Cases

For patients with recurrent or persistent subconjunctival hemorrhages, systematic investigation is mandatory to exclude underlying pathology 1:

  • Check blood pressure and screen for diabetes 1
  • Review anticoagulation therapy and bleeding disorder history 1
  • Look for a salmon-pink conjunctival lesion, which suggests possible ocular adnexal lymphoma—this is a critical finding that requires biopsy 1, 3
  • Any conjunctival nodules or granulomas warrant biopsy 1
  • Consider hemostatic screening only if there are other bleeding manifestations, as the prevalence of hemostatic abnormalities in isolated recurrent SCH is not different from the general population 4

Critical Pitfalls to Avoid

  • Do not discontinue anticoagulation therapy for subconjunctival hemorrhage—these hemorrhages are considered a minor bleeding risk, are self-limiting, and do not compromise visual acuity 1, 2
  • Do not prescribe antibiotics for subconjunctival hemorrhage, as they are ineffective unless there is concurrent bacterial infection 2
  • Do not miss associated viral conjunctivitis—check for preauricular lymphadenopathy and follicular reaction, and manage the underlying viral infection with topical lubricants 2
  • Do not ignore persistent pain or signs of infection—these require further investigation beyond simple observation 2

Special Clinical Scenarios

Patients on Anticoagulation

  • Continue anticoagulation therapy without interruption 1, 2
  • Reassure patients that subconjunctival hemorrhage does not indicate dangerous bleeding 1

Associated with Viral Conjunctivitis

  • Focus management on the underlying viral infection 1, 2
  • Use topical lubricants for comfort 1, 2
  • Consider topical corticosteroids only for severe cases with marked chemosis, eyelid swelling, or membranous conjunctivitis, under close supervision 2

Long-term Topical Steroid Users

  • Be aware that chronic topical corticosteroid use substantially increases the prevalence of spontaneous subconjunctival hemorrhage due to steroid-induced vascular fragility 5

Follow-up Strategy

  • No follow-up is needed for isolated, first-time subconjunctival hemorrhage that resolves as expected 1
  • Schedule follow-up within 1-2 weeks only if symptoms of viral conjunctivitis persist 1, 2
  • For recurrent cases, follow-up should focus on investigating underlying systemic conditions rather than the hemorrhage itself 1

References

Guideline

Management of Frequent Subconjunctival Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Subconjunctival Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.